Megan Eva Griffiths

Megan Eva Griffiths

Auto-generated profile, based on publicly available information

Megan Eva Griffiths

School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Glasgow, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MGMegan E. Griffiths
Megan E. Griffiths
DMDiana K. Meza
Diana K. Meza
DHDaniel T. Haydon
Daniel T. Haydon
DSDaniel Streicker
Daniel Streicker
Transmissible vaccines are an emerging biotechnology that hold prospects to eliminate pathogens from wildlife populations. Such vaccines would genetically modify naturally occurring, nonpathogenic viruses (“viral vectors”) to express pathogen antigens while retaining their capacity to transmit. The epidemiology of candidate viral vectors within the target wildlife population has been notoriously challenging to resolve but underpins the selection of effective vectors prior to major investments in vaccine development. Here, we used spatiotemporally replicated deep sequencing to parameterize competing epidemiological mechanistic models of Desmodus rotundus betaherpesvirus (DrBHV), a proposed vector for a transmissible vaccine targeting vampire bat-transmitted rabies. Using 36 strain- and location-specific time series of prevalence collected over 6 y, we found that lifelong infections with cycles of latency and reactivation, combined with a high R 0 (6.9; CI: 4.39 to 7.85), are necessary to explain patterns of DrBHV infection observed in wild bats. These epidemiological properties suggest that DrBHV may be suited to vector a lifelong, self-boosting, and transmissible vaccine. Simulations showed that inoculating a single bat with a DrBHV-vectored rabies vaccine could immunize >80% of a bat population, reducing the size, frequency, and duration of rabies outbreaks by 50 to 95%. Gradual loss of infectious vaccine from vaccinated individuals is expected but can be countered by inoculating larger but practically achievable proportions of bat populations. Parameterizing epidemiological models using accessible genomic data brings transmissible vaccines one step closer to implementation.

1 May 2020 in Journal of General Virology
Verified
Journal Article
Open access
SMSarah Mole
Sarah Mole
AFArwa Ali A. Faizo
Arwa Ali A. Faizo
HHHegel Hernandez-Lopez
Hegel Hernandez-Lopez
MGMegan Griffiths
Megan Griffiths
ASAndrew Stevenson
Andrew Stevenson
Sheila GrahamSheila Graham
Sheila Graham
The infectious life cycle of human papillomaviruses (HPVs) is tightly linked to keratinocyte differentiation. Evidence suggests a sophisticated interplay between host gene regulation and virus replication. Alternative splicing is an essential process for host and viral gene expression, and is generally upregulated by serine arginine-rich splicing factors (SRSFs). SRSF activity can be positively or negatively controlled by cycles of phosphorylation/dephosphorylation. Here we show that HPV16 infection leads to accumulation of the paradigm SRSF protein, SRSF1, in the cytoplasm in a keratinocyte differentiation-specific manner. Moreover, HPV16 infection leads to increased levels of cytoplasmic and nuclear phosphorylated SRSF1. SR protein kinase 1 (SRPK1) phosphorylates SRSF1. Similar to HPV upregulation of SRSF1, we demonstrate HPV upregulation of SRPK1 via the viral E2 protein. SRPK1 depletion or drug inhibition of SRPK1 kinase activity resulted in reduced levels of SRSF1, suggesting that phosphorylation stabilizes the protein in differentiated HPV-infected keratinocytes. Together, these data indicate HPV infection stimulates the SRPK1–SRSF axis in keratinocytes.

23 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MGMegan E. Griffiths
Megan E. Griffiths
LBLaura Bergner
Laura Bergner
ABAlice Broos
Alice Broos
DMDiana K. Meza
Diana K. Meza
AFAna da Silva Filipe
Ana da Silva Filipe
DSDaniel Streicker
Daniel Streicker
Rabies is a viral zoonosis transmitted by vampire bats across Latin America. Substantial public health and agricultural burdens remain, despite decades of bats culls and livestock vaccinations. Virally vectored vaccines that spread autonomously through bat populations are a theoretically appealing solution to managing rabies in its reservoir host. We investigate the biological and epidemiological suitability of a vampire bat betaherpesvirus (DrBHV) to act as a vaccine vector. In 25 sites across Peru with serological and/or molecular evidence of rabies circulation, DrBHV infects 80–100% of bats, suggesting potential for high population-level vaccine coverage. Phylogenetic analysis reveals host specificity within neotropical bats, limiting risks to non-target species. Finally, deep sequencing illustrates DrBHV super-infections in individual bats, implying that DrBHV-vectored vaccines might invade despite the highly prevalent wild-type virus. These results indicate DrBHV as a promising candidate vector for a transmissible rabies vaccine, and provide a framework to discover and evaluate candidate viral vectors for vaccines against bat-borne zoonoses.

19 April 2022 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MGMegan E. Griffiths
Megan E. Griffiths
ABAlice Broos
Alice Broos
LBLaura Bergner
Laura Bergner
DMDiana K. Meza
Diana K. Meza
NSNicolás M Suárez
Nicolás M Suárez
DSDaniel Streicker
Daniel Streicker
Vaccination is a powerful tool in combating infectious diseases of humans and companion animals. In most wildlife, including reservoirs of emerging human diseases, achieving sufficient vaccine coverage to mitigate disease burdens remains logistically unattainable. Virally vectored “transmissible” vaccines that deliberately spread among hosts are a potentially transformative, but still theoretical, solution to the challenge of immunising inaccessible wildlife. Progress towards real-world application is frustrated by the absence of frameworks to guide vector selection and vaccine deployment prior to major in vitro and in vivo investments in vaccine engineering and testing. Here, we performed deep sequencing on field-collected samples of Desmodus rotundus betaherpesvirus (DrBHV), a candidate vector for a transmissible vaccine targeting vampire bat–transmitted rabies. We discovered 11 strains of DrBHV that varied in prevalence and geographic distribution across Peru. The phylogeographic structure of DrBHV strains was predictable from both host genetics and landscape topology, informing long-term DrBHV-vectored vaccine deployment strategies and identifying geographic areas for field trials where vaccine spread would be naturally contained. Multistrain infections were observed in 79% of infected bats. Resampling of marked individuals over 4 years showed within-host persistence kinetics characteristic of latency and reactivation, properties that might boost individual immunity and lead to sporadic vaccine transmission over the lifetime of the host. Further, strain acquisitions by already infected individuals implied that preexisting immunity and strain competition are unlikely to inhibit vaccine spread. Our results support the development of a transmissible vaccine targeting a major source of human and animal rabies in Latin America and show how genomics can enlighten vector selection and deployment strategies for transmissible vaccines.

6 March 2024 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
CSCecilia Sánchez
Cecilia Sánchez
KPKendra Phelps
Kendra Phelps
HFHannah Frank
Hannah Frank
MGMarike Geldenhuys-Venter
Marike Geldenhuys-Venter
MGMegan E. Griffiths
Megan E. Griffiths
KOKevin Olival
Kevin Olival
Over the past two decades, research on bat-associated microbes such as viruses, bacteria and fungi has dramatically increased. Here, we synthesize themes from a conference symposium focused on advances in the research of bats and their microbes, including physiological, immunological, ecological and epidemiological research that has improved our understanding of bat infection dynamics at multiple biological scales. We first present metrics for measuring individual bat responses to infection and challenges associated with using these metrics. We next discuss infection dynamics within bat populations of the same species, before introducing complexities that arise in multi-species communities of bats, humans and/or livestock. Finally, we outline critical gaps and opportunities for future interdisciplinary work on topics involving bats and their microbes.

29 January 2008 in Journal of Vegetation Science
Verified
Journal Article
Open access
PDF file
MLMike J Lawes
Mike J Lawes
MGMegan E. Griffiths
Megan E. Griffiths
JMJeremy J. Midgley
Jeremy J. Midgley
SBStéphane Boudreau
Stéphane Boudreau
HEHarriet A.C. Eeley
Harriet A.C. Eeley
CCColin A. Chapman
Colin A. Chapman